neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.
- 1 April 1998
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 16 (4) , 1340-1349
- https://doi.org/10.1200/jco.1998.16.4.1340
Abstract
PURPOSEIt remains a challenge to predict which women with axillary node-negative (ANN) breast cancer at greatest risk of relapse may benefit most from adjuvant therapy. Increases in neu/erbB-2 have...Keywords
This publication has 0 references indexed in Scilit: